In the eastern Democratic Republic of Congo, an American physician working among the sick became the face of a crisis that had been quietly building for weeks before anyone knew its true name. The Bundibugyo ebolavirus — rare, lethal, and resistant to the vaccines stockpiled for its more familiar cousin — spread through a gap in diagnostic attention, reaching cities of millions before the correct question was even asked. What unfolded in Bunia is a reminder that the distance between a contained outbreak and an international emergency is often measured not in miles, but in the time it takes to
American doctor contracts rare Ebola strain in Congo; testing delays fuel spread
American physician infected; six other Americans exposed including healthcare worker spouse; multiple deaths in DRC and spread to neighboring Uganda.
The virus had been given weeks to spread before anyone knew what it was
Mark
Why did it take so long to identify this as Ebola at all?
Mimi
The labs were looking for the wrong thing. They tested only for Zaire, the strain they knew. When Bundibugyo didn't match, it looked like something else entirely—just a fever outbreak. No one was looking for a rare variant.
Mark
So the testing infrastructure itself created the blind spot?
Mimi
Exactly. It wasn't negligence so much as a system built around what had happened before. When something new arrives, the system can't see it.
Mark
And in those weeks of delay, what was actually happening?
Mimi
The virus was moving. Out of camps, into cities. By the time they knew what it was, it had already reached places with millions of people.
Mark
What makes Bundibugyo different from Zaire beyond just being rare?
Mimi
There are no vaccines. No approved treatments. The medical tools that exist for Ebola don't work against this strain. You're starting from zero.
Mark
And Dr. Stafford—he was treating patients without knowing what he was treating?
Mimi
He was treating what looked like a fever outbreak. He had no reason to suspect Ebola, let alone a variant no one had identified yet. By the time the diagnosis came, he was already infected.
Mark
What happens to the other Americans who were exposed?
Mimi
They're being monitored. Some are high-risk. At least one is already showing symptoms. His wife, who worked alongside him, is under watch. They're all waiting to see if the virus takes hold.
O Pulso
- A rare Ebola strain with no approved vaccine or treatment is now confirmed across three major cities — Goma, Kinshasa, and Kampala — after weeks of misidentification allowed it to travel unchecked.
- Provincial labs tested only for the common Zaire strain, and when the Bundibugyo variant didn't match, the rising death toll was quietly mislabeled as an unusual tropical fever.
- Dr. Peter Stafford, an American missionary physician, is being airlifted to a German biocontainment facility while six other Americans — including his symptomatic wife — remain under urgent monitoring.
- Armed militia violence across eastern Congo has already produced dozens of attacks on healthcare workers, threatening to paralyze the three new treatment centers before they open.
- The WHO has declared a Public Health Emergency of International Concern, and the CDC has raised travel advisories, but the international response is racing to catch a virus that was given weeks of head start.
In the eastern Democratic Republic of Congo, an American physician working among the sick became the face of a crisis that had been quietly building for weeks before anyone knew its true name. The Bundibugyo ebolavirus — rare, lethal, and resistant to the vaccines stockpiled for its more familiar cousin — spread through a gap in diagnostic attention, reaching cities of millions before the correct question was even asked. What unfolded in Bunia is a reminder that the distance between a contained outbreak and an international emergency is often measured not in miles, but in the time it takes to recognize what one is looking at.
Dr. Peter Stafford was treating patients at a hospital in Bunia, working with the Christian mission organization Serge in eastern Congo, when he developed aggressive symptoms and tested positive for the Bundibugyo ebolavirus — a rare and particularly lethal strain. Six other Americans were exposed alongside him, including at least one already showing symptoms and his wife, who was placed under strict monitoring. Stafford was airlifted to Germany for specialized biocontainment treatment.
The outbreak's reach was made possible by a specific diagnostic failure. When the first deaths appeared on April 24, provincial laboratories in Ituri tested blood samples only against the Zaire strain — the common culprit in major regional epidemics. Bundibugyo, which does not match that profile, went unrecognized. Officials attributed the rising death toll to an unusual tropical fever, and weeks passed without contact tracing. The correct identification only came after samples reached the National Institute of Bio-Medical Research in Kinshasa, where genetic sequencing finally named the killer.
By then, the virus had already moved. It reached Goma, an eastern hub of over two million people, then Kinshasa, then crossed into Uganda with confirmed cases in Kampala. Unlike the Zaire strain, Bundibugyo has no approved vaccines or therapeutics — the emergency stockpiles maintained for Ebola outbreaks offered nothing.
The response now confronts a landscape fractured by more than biology. Militia violence across eastern Congo has intensified since early 2025, with documented attacks on healthcare workers complicating the operation of three newly announced treatment centers. The WHO declared a Public Health Emergency of International Concern in mid-May, and the CDC issued a Level 2 Travel Advisory with enhanced screening at U.S. ports of entry. The machinery of international response is moving — but it is weeks behind a virus that was never given reason to slow down.
Dr. Peter Stafford was treating patients at a hospital in Bunia when the virus found him. The American physician, working with the Christian mission organization Serge in the eastern Democratic Republic of Congo, developed aggressive symptoms while caring for the sick. By the time his infection was confirmed, he had become part of an unfolding crisis that would eventually touch six other Americans and force an international medical evacuation.
Stafford tested positive for the Bundibugyo ebolavirus, a rare and particularly lethal strain that had been circulating undetected for weeks. The World Health Organization formally declared it a Public Health Emergency of International Concern in mid-May, but the virus had already moved far beyond the rural mining camps where it first took hold. Among those exposed alongside Stafford were three classified as high-risk contacts, and at least one person who had already begun showing symptoms. His wife, also working at the facility, was placed under strict monitoring. Stafford himself was being airlifted to Germany for specialized biocontainment treatment—a measure reserved for the most severe cases.
The delay that allowed this to happen was not mysterious. It was traceable to a specific failure in how the outbreak was investigated. When the first deaths appeared on April 24, local provincial laboratories in Ituri began testing blood samples. But they screened exclusively for the Zaire ebolavirus, the most common strain responsible for major epidemics in the region. The Bundibugyo variant, when it did not match that profile, went unrecognized. Public health officials, seeing a rising death toll that did not fit the expected pattern, misdiagnosed the deaths as an unusual tropical fever. Weeks passed. Contact tracing, the most critical tool for containing an outbreak, never began. The truth only emerged after samples were flown to the National Institute of Bio-Medical Research in Kinshasa, where genetic sequencing finally identified what was actually killing people.
By then, the virus had already escaped. It had moved from isolated camps into Goma, an eastern economic hub with over two million residents. Cases appeared in Kinshasa, the nation's capital. The outbreak crossed into Uganda, with confirmed infections in Kampala. The Bundibugyo strain carries an additional burden: unlike Zaire, it has no approved vaccines or therapeutics. The emergency stockpiles that governments maintain for Ebola outbreaks were useless.
The response now faces obstacles beyond the biological. Eastern Congo is gripped by violence from armed militia groups that has intensified since January 2025, with dozens of documented attacks on healthcare workers. The Congolese Health Minister Samuel Roger Kamba announced three new treatment centers, but the security situation threatens to undermine their operation before they can begin. The CDC issued a Level 2 Travel Advisory for the region and implemented enhanced screening at U.S. ports of entry. The machinery of international public health response was mobilizing, but it was moving into a landscape already fractured by conflict and already weeks behind a virus that had been given time to spread.
Citações Notáveis
The multi-week diagnostic delay allowed the virus to break out of isolated rural mining camps and enter highly populated urban hubs.— Public health investigators
Quer a matéria completa?
Leia o original em Firstpost ↗
Health & Medicine